ClinicalTrials.Veeva

Menu

Exploring the Effects of Lactobacillus Paracasei PS23 on Workplace-related Stress Symptoms Among Office Workers

M

Mackay Memorial Hospital

Status

Terminated

Conditions

Stress

Treatments

Dietary Supplement: Probiotics

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05826704
22CT044be

Details and patient eligibility

About

A total of 120 subjects are expected to be recruited over a 3-year period starting after IRB approval, divided into two groups of 60 subjects, receiving PS23 or placebo, and completing a 6-week trial period.

Full description

There is still a lack of research to explore the interaction between high-pressure workers and probiotics to improve the intestinal microbiota and further affect its relationship with sleep, inflammation, and anti-oxidation, and further studies are still needed to confirm the clinical effect. A total of 120 subjects are expected to be recruited over a 3-year period starting after IRB approval, divided into two groups of 60 subjects, receiving PS23 or placebo, and completing a 6-week trial period.

Enrollment

50 patients

Sex

All

Ages

20 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Administrative staff of JARLLYTEC CO., LTD.
  2. Age 20-65 years old
  3. Those who feel that they are in a medium to high stress situation

Exclusion criteria

  1. Have taken antibiotics within one month or are receiving antibiotic treatment
  2. Have taken probiotic products within two weeks (excluding yogurt, yogurt, Yakult and other related foods)
  3. have a history of cancer
  4. Those who are allergic to lactic acid bacteria products
  5. Those who are currently taking medication for acute illness, mental illness or sleep disorder
  6. Pregnant or breastfeeding
  7. The project host judges that it is not suitable to participate in the researcher

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

50 participants in 2 patient groups, including a placebo group

PS23
Experimental group
Description:
2 capsule daily
Treatment:
Dietary Supplement: Probiotics
Placebo
Placebo Comparator group
Description:
2 capsule daily
Treatment:
Dietary Supplement: Probiotics

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems